Logo image of STEX

STREAMEX CORP (STEX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:STEX - US09073N3008 - Common Stock

3.12 USD
-0.09 (-2.8%)
Last: 1/9/2026, 8:28:23 PM
3.12 USD
0 (0%)
After Hours: 1/9/2026, 8:28:23 PM
Fundamental Rating

0

STEX gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. STEX may be in some trouble as it scores bad on both profitability and health. STEX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

STEX had negative earnings in the past year.
In the past year STEX has reported a negative cash flow from operations.
STEX had negative earnings in each of the past 5 years.
STEX had a negative operating cash flow in each of the past 5 years.
STEX Yearly Net Income VS EBIT VS OCF VS FCFSTEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

STEX has a Return On Assets (-30.57%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -30.57%
ROE N/A
ROIC N/A
ROA(3y)-1175.93%
ROA(5y)-781.08%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
STEX Yearly ROA, ROE, ROICSTEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

1.3 Margins

STEX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
STEX Yearly Profit, Operating, Gross MarginsSTEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50K -100K -150K

0

2. Health

2.1 Basic Checks

STEX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, STEX has more shares outstanding
STEX has more shares outstanding than it did 5 years ago.
There is no outstanding debt for STEX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
STEX Yearly Shares OutstandingSTEX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
STEX Yearly Total Debt VS Total AssetsSTEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of -2.86, we must say that STEX is in the distress zone and has some risk of bankruptcy.
STEX has a Altman-Z score of -2.86. This is in the lower half of the industry: STEX underperforms 64.86% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.86
ROIC/WACCN/A
WACC9.82%
STEX Yearly LT Debt VS Equity VS FCFSTEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

A Current Ratio of 0.12 indicates that STEX may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.12, STEX is doing worse than 96.22% of the companies in the same industry.
STEX has a Quick Ratio of 0.12. This is a bad value and indicates that STEX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of STEX (0.12) is worse than 95.14% of its industry peers.
Industry RankSector Rank
Current Ratio 0.12
Quick Ratio 0.12
STEX Yearly Current Assets VS Current LiabilitesSTEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

1

3. Growth

3.1 Past

STEX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 80.81%, which is quite impressive.
STEX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -63.89%.
STEX shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -55.07% yearly.
EPS 1Y (TTM)80.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-289.42%
Revenue 1Y (TTM)-63.89%
Revenue growth 3Y-55.07%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 37.81% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y68.52%
EPS Next 2Y40.08%
EPS Next 3Y37.81%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
STEX Yearly Revenue VS EstimatesSTEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2026 2027 50M 100M
STEX Yearly EPS VS EstimatesSTEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 0 -5 -10 -15 -20

1

4. Valuation

4.1 Price/Earnings Ratio

STEX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for STEX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
STEX Price Earnings VS Forward Price EarningsSTEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
STEX Per share dataSTEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

STEX's earnings are expected to grow with 37.81% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.08%
EPS Next 3Y37.81%

0

5. Dividend

5.1 Amount

No dividends for STEX!.
Industry RankSector Rank
Dividend Yield 0%

STREAMEX CORP

NASDAQ:STEX (1/9/2026, 8:28:23 PM)

After market: 3.12 0 (0%)

3.12

-0.09 (-2.8%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-14 2025-11-14
Earnings (Next)04-13 2026-04-13/amc
Inst Owners7.82%
Inst Owner ChangeN/A
Ins Owners2.48%
Ins Owner Change35.35%
Market Cap463.66M
Revenue(TTM)13.00K
Net Income(TTM)-39.89M
Analysts82.86
Price Target12.24 (292.31%)
Short Float %7.82%
Short Ratio3.33
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)20%
PT rev (3m)20%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-25%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 35666.4
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.81
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0
BVpS-0.05
TBVpS-0.82
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -30.57%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-1175.93%
ROA(5y)-781.08%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.12
Quick Ratio 0.12
Altman-Z -2.86
F-Score3
WACC9.82%
ROIC/WACCN/A
Cap/Depr(3y)36.29%
Cap/Depr(5y)95.03%
Cap/Sales(3y)364.03%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)80.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-289.42%
EPS Next Y68.52%
EPS Next 2Y40.08%
EPS Next 3Y37.81%
EPS Next 5YN/A
Revenue 1Y (TTM)-63.89%
Revenue growth 3Y-55.07%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-74.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3Y114.46%
EBIT Next 5YN/A
FCF growth 1Y57.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y57.3%
OCF growth 3YN/A
OCF growth 5YN/A

STREAMEX CORP / STEX FAQ

What is the ChartMill fundamental rating of STREAMEX CORP (STEX) stock?

ChartMill assigns a fundamental rating of 0 / 10 to STEX.


What is the valuation status for STEX stock?

ChartMill assigns a valuation rating of 1 / 10 to STREAMEX CORP (STEX). This can be considered as Overvalued.


Can you provide the profitability details for STREAMEX CORP?

STREAMEX CORP (STEX) has a profitability rating of 0 / 10.


Can you provide the financial health for STEX stock?

The financial health rating of STREAMEX CORP (STEX) is 0 / 10.